Management of Indwelling Tunneled Pleural Catheters: A Modified Delphi Consensus Statement.

indwelling tunneled pleural catheter malignant pleural effusion pleural catheter infection pleural catheter management pleurodesis

Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
11 2020
Historique:
received: 19 11 2019
revised: 04 04 2020
accepted: 17 05 2020
pubmed: 21 6 2020
medline: 25 5 2021
entrez: 21 6 2020
Statut: ppublish

Résumé

The management of recurrent pleural effusions remains a challenging issue for clinicians. Advances in management have led to increased use of indwelling tunneled pleural catheters (IPC) because of their effectiveness and ease of outpatient placement. However, with the increase in IPC placement there have also been increasing reports of complications, including infections. Currently there is minimal guidance in IPC-related management issues after placement. Our objective was to formulate clinical consensus statements related to perioperative and long-term IPC catheter management based on a modified Delphi process from experts in pleural disease management. Expert panel members used a modified Delphi process to reach consensus on common perioperative and long-term management options related to IPC use. Members were identified from multiple countries, specialties, and practice settings. A series of meetings and anonymous online surveys were completed. Responses were used to formulate consensus statements among panel experts, using a modified Delphi process. Consensus was defined a priori as greater than 80% agreement among panel constituents. A total of 25 physicians participated in this project. The following topics were addressed during the process: definition of an IPC infection, management of IPC-related infectious complications, interventions to prevent IPC infections, IPC-related obstruction/malfunction management, assessment of IPC removal, and instructions regarding IPC management by patients and caregivers. Strong consensus was obtained on 36 statements. No consensus was obtained on 29 statements. The management of recurrent pleural disease with IPC remains complex and challenging. This statement offers statements for care in numerous areas related to IPC management based on expert consensus and identifies areas that lack consensus. Further studies related to long-term management of IPC are warranted.

Sections du résumé

BACKGROUND
The management of recurrent pleural effusions remains a challenging issue for clinicians. Advances in management have led to increased use of indwelling tunneled pleural catheters (IPC) because of their effectiveness and ease of outpatient placement. However, with the increase in IPC placement there have also been increasing reports of complications, including infections. Currently there is minimal guidance in IPC-related management issues after placement.
RESEARCH QUESTION
Our objective was to formulate clinical consensus statements related to perioperative and long-term IPC catheter management based on a modified Delphi process from experts in pleural disease management.
STUDY DESIGN AND METHODS
Expert panel members used a modified Delphi process to reach consensus on common perioperative and long-term management options related to IPC use. Members were identified from multiple countries, specialties, and practice settings. A series of meetings and anonymous online surveys were completed. Responses were used to formulate consensus statements among panel experts, using a modified Delphi process. Consensus was defined a priori as greater than 80% agreement among panel constituents.
RESULTS
A total of 25 physicians participated in this project. The following topics were addressed during the process: definition of an IPC infection, management of IPC-related infectious complications, interventions to prevent IPC infections, IPC-related obstruction/malfunction management, assessment of IPC removal, and instructions regarding IPC management by patients and caregivers. Strong consensus was obtained on 36 statements. No consensus was obtained on 29 statements.
INTERPRETATION
The management of recurrent pleural disease with IPC remains complex and challenging. This statement offers statements for care in numerous areas related to IPC management based on expert consensus and identifies areas that lack consensus. Further studies related to long-term management of IPC are warranted.

Identifiants

pubmed: 32561437
pii: S0012-3692(20)31676-7
doi: 10.1016/j.chest.2020.05.594
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2221-2228

Subventions

Organisme : Marie Curie
ID : MCCC-RP-14-A17178
Pays : United Kingdom

Informations de copyright

Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Auteurs

Christopher R Gilbert (CR)

Department of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA. Electronic address: christopher.gilbert@swedish.org.

Momen M Wahidi (MM)

Division of Pulmonary and Critical Care, Duke University, Durham, NC.

Richard W Light (RW)

Division of Allergy, Pulmonary and Critical Care, Vanderbilt University, Nashville, TN.

M Patricia Rivera (MP)

Division of Pulmonary and Critical Care, University of North Carolina, Chapel Hill, NC.

Daniel H Sterman (DH)

Division of Pulmonary, Critical Care and Sleep Medicine, New York University, New York, NY.

Rajesh Thomas (R)

Department of Respiratory Medicine, Sir Charles Gardiner Hospital, Perth, Western Australia, Australia.

Samira Shojaee (S)

Division of Pulmonary and Critical Care Medicine, Virginia Commonwealth University, Richmond, VA.

Shmuel Shoham (S)

Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, MD.

Ioannis Psallidas (I)

Centre for Respiratory Medicine, University College London, London, England.

David E Ost (DE)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

Daniela Molena (D)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Nick Maskell (N)

Academic Respiratory Unit, University of Bristol Medical School, Bristol, England.

Fabien Maldonado (F)

Division of Allergy, Pulmonary and Critical Care, Vanderbilt University, Nashville, TN.

Moishe Liberman (M)

Division of Thoracic Surgery, Department of Surgery, University of Montreal, Montreal, Quebec, Canada.

Y C Gary Lee (YCG)

Department of Respiratory Medicine, Sir Charles Gardiner Hospital, Perth, Western Australia, Australia.

Hans Lee (H)

Division of Pulmonary and Critical Care, Johns Hopkins School of Medicine, Baltimore, MD.

Felix J F Herth (FJF)

Department of Pneumology and Critical Care Medicine, Thoraxklinik, Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), University of Heidelberg, Heidelberg, Germany.

Horiana Grosu (H)

Department of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

Jed A Gorden (JA)

Department of Thoracic Surgery and Interventional Pulmonology, Swedish Cancer Institute, Seattle, WA.

Edward T H Fysh (ETH)

Department of Respiratory Medicine, Sir Charles Gardiner Hospital, Perth, Western Australia, Australia.

John P Corcoran (JP)

Department of Respiratory Medicine, University Hospitals Plymouth NHS Trust, Plymouth, England.

A Christine Argento (AC)

Division of Pulmonary and Critical Care, Northwestern University, Chicago, IL.

Jason A Akulian (JA)

Division of Pulmonary and Critical Care, University of North Carolina, Chapel Hill, NC.

Najib M Rahman (NM)

Oxford Centre for Respiratory Medicine, Churchill Hospital, University of Oxford, Oxford, England, and Oxford NIHR Biomedical Research Centre.

Lonny B Yarmus (LB)

Division of Pulmonary and Critical Care, Johns Hopkins School of Medicine, Baltimore, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH